As of Aug 28
| +0.07 / +3.02%|
The 3 analysts offering 12-month price forecasts for CytRx Corp have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +234.73% increase from the last price of 2.39.
The current consensus among 3 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.